Ferring B.V. et al v. Allergan Inc. et al
| Ferring B.V., Ferring International Center S.A. and Ferring Pharmaceuticals Inc. |
| Allergan Inc., Allergan USA, Inc., Allergan Sales, LLC, Serenity Pharmaceuticals Corporation, Serenity Pharmaceuticals, LLC, Reprise Biopharmaceutics, LLC, Seymour H. Fein and Ronald V. Nardi |
| 1:2012cv02650 |
| April 5, 2012 |
| US District Court for the Southern District of New York |
| Foley Square Office |
| XX Out of U.S. |
| Robert W. Sweet |
| Patent |
| 35 U.S.C. ยง 145 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
492
ORDER: For the reasons set forth in the transcript of the proceeding held on August 24, 2021, Ferring's motion for sanctions (doc 474) is DENIED. The Clerk is directed to terminate the motion and close the case. (Signed by Judge P. Kevin Castel on 8/24/2021) (rro)
|
|
Filing
491
ORDER: The oral argument scheduled for 11:00 a.m. on August 24, 2021 will now take place at 4:00 p.m. on that same day in Courtroom 11D, 500 Pearl Street, New York, New York. ( Oral Argument set for 8/24/2021 at 04:00 PM in Courtroom 11D, 500 Pearl Street, New York, NY 10007 before Judge P. Kevin Castel.) (Signed by Judge P. Kevin Castel on 8/19/2021) (ate)
|
|
Filing
490
ORDER: The Court will hold oral argument on Ferrings motion for sanctions (doc 474) on August 24, 2021 at 11:00 a.m. in Courtroom 11D, 500 Pearl Street, New York, New York. SO ORDERED., Oral Argument set for 8/24/2021 at 11:00 AM in Courtroom 11D, 500 Pearl Street, New York, NY 10007 before Judge P. Kevin Castel. (Signed by Judge P. Kevin Castel on 7/29/2021) (rj)
|
|
Filing
484
MEMO ENDORSEMENT on 481 granting Motion to Seal. ENDORSEMENT: The Documents are provisionally sealed subject to further Order. SO ORDERED. (Signed by Judge P. Kevin Castel on 3/30/2021) (ama)
|
|
Filing
476
ORDER. Ferring's motion to dismiss the remaining claims in this case with prejudice is GRANTED. The claims are dismissed as moot. The Clerk is directed to terminate the motion (Doc 473). SO ORDERED. Granting 473 Motion to Dismiss. (Signed by Judge P. Kevin Castel on 3/23/2021) (rjm) Transmission to Orders and Judgments Clerk for processing.
|
|
Filing
434
OPINION AND ORDER: re: 373 MOTION to Vacate 190 Memorandum & Opinion filed by Ferring Pharmaceuticals Inc., Ferring B.V., Ferring International Center S.A. Ferring's motion for reconsideration is DENIED. The Clerk is directed to terminate the motion (Doc 373.) SO ORDERED. (Signed by Judge P. Kevin Castel on 7/18/2019) (ama)
|
|
Filing
354
OPINION and ORDER re: 343 MOTION for Certificate of Appealability Pursuant to 28 U.S.C. 1292(b). filed by Ferring Pharmaceuticals Inc., Ferring B.V., Ferring International Center S.A. Plaintiffs Ferring B.V., Ferring Internatio nal Center S.A., and Ferring Pharmaceuticals Inc. ("Ferring," the "Plaintiffs," or the "Counter-Defendants") have moved to certify this Court's May 24, 2018 decision ("Standing Decision" or "Standing Opinion") for interlocutory appeal under 28 U.S.C. § 1292(b) and for a stay pending the outcome of the appeal. (As further set forth in this Order.) For the reasons set forth above, Plaintiff's motion for a certificate of appealability is granted as to this Court's Standing Finding and its motion for a stay is granted. (Signed by Judge Robert W. Sweet on 9/14/2018) (cf)
|
|
Filing
342
OPINION AND ORDER. For the reasons set forth above, Ferring's motion for judgment on partial findings is denied and Reprise and Serenity's motion for substitution of parties is dismissed as moot. In light of the protective order entered in this case (Dkt. 124), the parties are directed to jointly submit a redacted version of this Opinion to be filed publicly within one week of the date of this Opinion. Parties are ordered to meet and confer on the resumption of trial. It is so ordered. re: 318 MOTION for Joinder or Ratification under Fed. R. Civ. P. 17 filed by Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals, LLC. (Signed by Judge Robert W. Sweet on 5/24/2018) (rjm)
|
|
Filing
294
SEALED OPINION: For the reasons set forth above, Ferring's motion to dismiss is denied, Counterclaim Plaintiffs and Al lergan's motion for substitution is granted, and both parties' motions to seal are granted. The Clerk of the Court i s requested to amend the caption by substituting Reprise and Serenity for Allergan as counterclaimants. In light of the protective order entered in this case, the parties are directed to jointly submit a redacted version of this Opinion to be filed publically within one week of the date of this Opinion. So Ordered. (Signed by Judge Robert W. Sweet on 9/7/2017) (js)
|
|
Filing
241
OPINION re: 227 MOTION in Limine / NOTICE OF ALLERGAN'S MOTION IN LIMINE #2: TO EXCLUDE OPINIONS AND OTHER TESTIMONY OF RIKARD SANDSTROM. filed by Allergan Sales, LLC, Allergan USA, Inc., Allergan Inc., 225 MOTION in Limine / NOTICE OF ALLERGAN'S MOTION IN LIMINE #1: TO EXCLUDE TESTIMONY OR EVIDENCE RELATING TO BUSINESS NEGOTIATIONS AND DUE DILIGENCE PRECEDING THE MARCH 2010 AGREEMENT BETWEEN ALLERGAN, SERENITY, AND REPRISE. filed by Allergan Sales , LLC, Allergan USA, Inc., Allergan Inc. The motion in limine of Allergan to preclude evidence of due diligence and by Sandstrom is granted in part and denied in part as set forth above. It is so ordered. (As further set forth in this order) (Signed by Judge Robert W. Sweet on 10/28/2016) (lmb)
|
|
Filing
237
SEALED OPINION re: 218 MOTION for Entry of Judgment under Rule 54(b) and Stay of Trial Proceedings filed by Ferring Pharmaceuticals Inc., Ferring B.V., Ferring International Center S.A. Based on the conclusions set forth abov e, Plaintiff' s motion for certification of judgments and stay of trial proceedings, ECF No. 218, is denied. In light of the confidentiality stipulation and order entered in this case, the parties are directed to jointly submit a redacted versi on of this opinion to be filed publicly or otherwise notify the Court that no redactions are necessary within two weeks of the date of distribution of this opinion. It is so ordered. (As further set forth in this Opinion.) (Signed by Judge Robert W. Sweet on 6/8/2016) (This document was previously filed under seal in envelope #235 and unsealed on 6/14/2016.)(mro)
|
|
Filing
88
OPINION re: 69 MOTION to Amend/Correct 1 Complaint, for leave to file Second Amended Complaint, filed by Ferring Pharmaceuticals Inc., Ferring B.V., Ferring International Center S.A. For the foregoing reasons, Plaintiffs' motion for leave to amend is denied in its entirety. It is so ordered. (Signed by Judge Robert W. Sweet on 3/7/2014) (ajs)
|
|
Filing
67
OPINION re: 59 MOTION for Reconsideration or, Alternatively, to File an Amended Complaint filed by Ferring Pharmaceuticals Inc., Ferring B.V., Ferring International Center S.A. Accordingly, the motion for reconsideration is denied and the alternative motion to amend is denied, without prejudice to permit Ferring to move for leave to amend in compliance with the March 28 Order. (Signed by Judge Robert W. Sweet on 8/5/2013) (cd)
|
|
Filing
57
OPINION re: 26 MOTION to Dismiss filed by Allergan Sales, LLC, Allergan USA, Inc., Allergan Inc. Based upon the facts and conclusions set forth above, the Defendant's motion to dismiss is granted as to all counts, except for Counts 1 through 3. (Signed by Judge Robert W. Sweet on 3/18/2013) (cd)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
